Complete financial analysis of DFP Healthcare Acquisitions Corp. (DFPH) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of DFP Healthcare Acquisitions Corp., a leading company in the Shell Companies industry within the Financial Services sector.
- Lafayette Energy Corp (LEC) Income Statement Analysis – Financial Results
- Almunda Professionals N.V. (AMUND.AS) Income Statement Analysis – Financial Results
- Rani Therapeutics Holdings, Inc. (RANI) Income Statement Analysis – Financial Results
- Orrön Energy AB (publ) (LUNE.ST) Income Statement Analysis – Financial Results
- Public Joint Stock Company Rosseti Volga (MRKV.ME) Income Statement Analysis – Financial Results
DFP Healthcare Acquisitions Corp. (DFPH)
Industry: Shell Companies
Sector: Financial Services
About DFP Healthcare Acquisitions Corp.
DFP Healthcare Acquisitions Corp. intends to acquire assets and businesses through a merger, capital stock exchange, stock purchase, reorganization or other similar business combination. The company was founded in 2019 and is based in New York, New York.
Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
---|---|---|---|---|---|---|
Revenue | 324.24M | 252.48M | 203.00M | 187.51M | 155.41M | 113.16M |
Cost of Revenue | 264.67M | 200.39M | 162.16M | 150.64M | 125.46M | 86.88M |
Gross Profit | 59.57M | 52.09M | 40.85M | 36.88M | 29.94M | 26.28M |
Gross Profit Ratio | 18.37% | 20.63% | 20.12% | 19.67% | 19.27% | 23.23% |
Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
General & Administrative | 0.00 | 0.00 | 0.00 | 309.17K | 0.00 | 0.00 |
Selling & Marketing | 0.00 | 0.00 | 0.00 | 41.59M | 0.00 | 0.00 |
SG&A | 113.85M | 119.69M | 83.37M | 41.90M | 29.64M | 20.39M |
Other Expenses | 22.74M | 4.41M | 3.34M | 3.18M | 2.94M | 1.10M |
Operating Expenses | 136.59M | 124.10M | 86.71M | 45.07M | 32.59M | 21.49M |
Cost & Expenses | 401.26M | 324.49M | 248.86M | 195.71M | 158.05M | 108.37M |
Interest Income | 0.00 | 4.08M | 320.00K | 254.15K | 3.38K | 0.00 |
Interest Expense | 6.78M | 4.08M | 320.00K | 347.06K | 3.38K | 1.59K |
Depreciation & Amortization | 5.87M | 4.41M | 3.34M | 3.18M | 2.94M | 1.10M |
EBITDA | -70.45M | 8.40M | -7.94M | -11.29M | 307.11K | 9.08M |
EBITDA Ratio | -21.73% | -26.57% | -20.43% | -6.02% | 0.20% | 5.27% |
Operating Income | -77.02M | -72.01M | -45.86M | -8.20M | -2.63M | 4.79M |
Operating Income Ratio | -23.75% | -28.52% | -22.59% | -4.37% | -1.70% | 4.23% |
Total Other Income/Expenses | -6.09M | 81.86M | 34.26M | -6.62M | 6.63K | 71.18K |
Income Before Tax | -83.10M | 1.90M | -11.60M | -14.81M | -2.64M | 4.86M |
Income Before Tax Ratio | -25.63% | 0.75% | -5.71% | -7.90% | -1.70% | 4.30% |
Income Tax Expense | -36.00K | 247.00K | -671.00K | -492.82K | 1.38M | 912.75K |
Net Income | -83.07M | 1.66M | -10.93M | -14.32M | -4.02M | 3.95M |
Net Income Ratio | -25.62% | 0.66% | -5.38% | -7.64% | -2.59% | 3.49% |
EPS | -0.92 | 0.02 | -0.16 | -0.24 | -0.06 | 0.14 |
EPS Diluted | -0.92 | 0.02 | -0.16 | -0.24 | -0.06 | 0.14 |
Weighted Avg Shares Out | 73.75M | 72.79M | 66.23M | 59.12M | 64.45M | 28.75M |
Weighted Avg Shares Out (Dil) | 73.75M | 80.61M | 66.23M | 59.12M | 64.45M | 28.75M |
The Oncology Institute Physician, Dr. John Khoury, Receives 40 Under 40 in Cancer Award
DFP Healthcare Acquisitions Corp. Announces Special Meeting Date to Approve Proposed Business Combination with The Oncology Institute
DFP Healthcare Acquisitions Corp. Announces Proposed Business Combination With The Oncology Institute
Trade-In Lame 0.5% Bonds For Secure Yields Up To 7.5%
Source: https://incomestatements.info
Category: Stock Reports